Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Response Genetics Inc.

Division of Cancer Genetics Inc.
www.responsegenetics.com

Latest From Response Genetics Inc.

Device/Diagnostics Quarterly Deal Statistics, Q3 2015

$1.4 billion in Q3 device financing was slightly lower than Q2's $1.8 billion with just one IPO versus Q2's seven. Acquisitions reached a high of $23 billion and diagnostics financing increased 30% over Q2 to $1 billion, while M&A activity at $1.2 billion showed a sharp decline from the previous quarter's $15.6 billion.

Medical Device Deals

One Test’s Odyssey: Cancer Of Unknown Origin

In recent years Pathwork Diagnostics Inc. and Rosetta Genomics Ltd. have developed tests that use the molecular makeup of the cancer cells to provide insight on the cancer’s origin.

BioPharmaceutical Medical Device

Medical Device Deals Update, September 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced in late July-September 2014.

Medical Device Deals

Medical Device Deals Update, October 2012

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cancer Genetics Inc.
  • Senior Management
  • Thomas A Bologna, Chmn. & CEO
    Kevin R Harris, CFO
    Stephanie H Astrow, PhD, VP, R&D
    Mark Balsano, VP, Sales
  • Contact Info
  • Response Genetics Inc.
    Phone: (323) 224-3900
    1640 Marengo St. 6th Floor
    Los Angeles, CA 90033
    USA
UsernamePublicRestriction

Register